Not Yet Recruiting
Luvometinib in Combination With Serplulimab for NF2-Related Tumors
NCT07708285
- Conditions
- Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +35 more
- Locations
-
- Xuanwu Hospital, Capital Medical University Beijing, Beijing Municipality, China
- Beijing Tiantan Hospital, Capital Medical University Beijing, Beijing Municipality, China
- Chinese PLA General Hospital Beijing, Beijing Municipality, China
- The First Hospital of Jilin University Changchun, Jilin, China